{
    "clinical_study": {
        "@rank": "8243", 
        "acronym": "K2vita", 
        "arm_group": [
            {
                "arm_group_label": "K2 vitamin", 
                "arm_group_type": "Experimental", 
                "description": "K2 vitamin 375 microgram a day for 1 year"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "1 tablet a day for 1 year"
            }
        ], 
        "brief_summary": {
            "textblock": "The aims of the present study are to investigate the effect of vitamin K2 on bone turnover,\n      bone mass, bone structure, glucose metabolism, and arteriosclerosis.\n\n      Osteoporosis, diabetes, metabolic syndrome and cardiovascular disease are common diseases\n      that affect large groups of people in the Western world.\n\n      Our hypotheses is that vitamin K2 (MK-7) reduces undercarboxylated osteocalcin in\n      postmenopausal women and reduces bone turnover and increases bone mineral density; increases\n      insulin sensitivity and decreases indices of arterial calcification."
        }, 
        "brief_title": "Investigations of the Effect of MK-7 on Bone and Glucose Metabolism and Arterial Calcification", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Metabolic Bone Disorder", 
        "condition_browse": {
            "mesh_term": [
                "Bone Diseases", 
                "Bone Diseases, Metabolic", 
                "Calcinosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Osteoporosis, diabetes, metabolic syndrome and cardiovascular disease are common diseases\n      that affect large groups of people in the Western world.\n\n      Our hypotheses is that vitamin K2 (MK-7) reduces undercarboxylated osteocalcin in\n      postmenopausal women and reduces bone turnover and increases bone mineral density; increases\n      insulin sensitivity and decreases indices of arterial calcification."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  postmenopausal women\n\n          -  60-80 years\n\n          -  osteopenia\n\n        Exclusion Criteria:\n\n          -  Calcium metabolic, thyroid, liver or kidney disease\n\n          -  Diabetes\n\n          -  Obesity\n\n          -  Myocardial infarction or other arteriosclerotic events\n\n          -  Angina pectoris\n\n          -  Vitamin D < 50 nmol/L\n\n          -  Treatment with vitamin K antagonists\n\n          -  Use of vitamin K supplements in the last month or for more than 3 months at any time\n\n          -  Treatment with drugs with known effects on bone metabolism or glucose metabolism.\n\n          -  Smoking in the last 12 months\n\n          -  Drug or alcohol abuse\n\n          -  Allergy to calcium, vitamin D or vitamin K."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01922804", 
            "org_study_id": "K2vita"
        }, 
        "intervention": [
            {
                "arm_group_label": "K2 vitamin", 
                "description": "K2 vitamin tablet", 
                "intervention_name": "K2 vitamin", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "Placebo tablets", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Vitamins"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 13, 2013", 
        "location": {
            "contact": {
                "email": "nanroe@rm.dk", 
                "last_name": "Sofie Roenn, cand.med."
            }, 
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "zip": "8000"
                }, 
                "name": "Department of Endocrinology and Internal Medicine THG"
            }, 
            "investigator": {
                "last_name": "Sofie Roenn, cand.med.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Investigations of the Effect of MK-7 on Bone and Glucose Metabolism and Arterial Calcification", 
        "overall_contact": {
            "email": "nanroe@rm.dk", 
            "last_name": "Sofie Roenn, cand.med."
        }, 
        "overall_official": {
            "affiliation": "Aarhus University Hospital", 
            "last_name": "Sofie R\u00f8nn, cand.med", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "p-undercarboxylated osteocalcin", 
            "safety_issue": "No", 
            "time_frame": "Change in undercarboxylated osteocalcin in plasma after 3 month treatment compared to baseline. Analysed in batch after the end of trial."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01922804"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Change in bone mineral density measured by DXA scans (Dual energy x-ray absorptiometry)", 
                "measure": "Change in bone mineral density", 
                "safety_issue": "No", 
                "time_frame": "Assessed after 3, 6 and 12 months"
            }, 
            {
                "description": "Change in pulse wave velocity after 6 months.", 
                "measure": "Change in arterial stiffness, pulse wave velocity", 
                "safety_issue": "No", 
                "time_frame": "Measured at baseline and after 6 months"
            }, 
            {
                "description": "Change in insulin sensitivity. Determined by HOMA-test (homeostasis model assessment), using fasting plasma glucose and insulin.", 
                "measure": "Change in insulin sensitivity", 
                "safety_issue": "No", 
                "time_frame": "Measured at baseline and after 1 months"
            }, 
            {
                "measure": "Change in bone turnover markers", 
                "safety_issue": "No", 
                "time_frame": "Measured at baseline, after 1, 3, 6 and 12 months"
            }, 
            {
                "description": "HRpQCT scans", 
                "measure": "Change in bone structure", 
                "safety_issue": "No", 
                "time_frame": "baseline and month 12"
            }
        ], 
        "source": "University of Aarhus", 
        "sponsors": {
            "collaborator": {
                "agency": "axellus", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}